loader
Please Wait
Applying Filters...

Looking for SULFUR? Find Controlled & Modified Release used in SULFUR to address drug delivery challenges on PharmaCompass.

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Evonik

02 5Gangwal Healthcare

03 5Nanjing Well Pharmaceutical

04 5Actylis

05 5Aeon Procare

06 4Alcedo Pharmachem

07 13BASF

08 20Corel Pharma Chem

09 7Finar

10 1Huzhou Sunflower Pharmaceutical

11 5Ideal Cures Pvt Ltd

12 15Kerry

13 1Kima Chemical

14 1Lonza Capsugel

15 8Lubrizol Life Science Health

16 2Nomisma Healthcare

17 2Novo Excipients

18 2Pluviaendo

19 1Sigachi Industries

20 2The Dow Chemical Company

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEvonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Grade : Oral

Brand Name : EUDRAGIT® L 100

Excipient Details : EUDRAGIT® L 100, a functional delayed release polymer is used to increase solubility of poorly soluble products such as tablets, capsules, ODTs, etc.

Pharmacopoeia Ref : NA

Technical Specs : Available as powder; Other grades- EUDRAGIT® L 12,5

Grade : Oral

arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEvonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Brand : EUDRAGIT® L 100

Applications : EUDRAGIT® L 100, a functional delayed release polymer is used to increase solubility of poorly soluble products such as tablets, capsules, ODTs, etc.

Pharmacopoeia Ref : NA

Technical Specs : Available as powder; Other grades- EUDRAGIT® L 12,5

Grade : Oral

arrow

03

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

Grade : Parenteral, Topical, Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Grade : Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Brand : GELLETS-P®

Applications : Gellets-P are Microcrystalline Cellulose based spheres for the manufacturing of pellets and modified release products.

Pharmacopoeia Ref : In-house

Technical Specs : NA

Grade : Oral

arrow

06

arrow
2024 ACI Convention
Not Confirmed

07

arrow
2024 ACI Convention
Not Confirmed

08

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : KOLLIDON SR

Applications : For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.

Pharmacopoeia Ref : Ph. Eur., USP-NF, JP-JPE: 80 % Polyvinyl acetate and 19 % povidone, 0.8 % lauryl sulfate & 0.2 % silica (4:1)

Technical Specs : Not Available

Grade : Not Available

arrow
blank

09

arrow
2024 ACI Convention
Not Confirmed

10

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand Name : PLGA-PEG

Excipient Details : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.

Grade : Oral, Parenteral

arrow

Brand : PLGA-PEG

Applications : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.

Grade : Oral, Parenteral

arrow
blank

11

arrow
2024 ACI Convention
Not Confirmed

13

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

15

arrow
2024 ACI Convention
Not Confirmed

19

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : ESPHERES EM

Applications : These spheres can be used as an inert base for modified release formulations promoting consistency and uniformity of release profile thus ensuring a uniform therapeutic response.

Pharmacopoeia Ref : Particle Sizes - #20 – #30, #30 – #40 and #40 – #60

Technical Specs : Not Available

Grade : Oral

arrow
blank

21

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

24

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : METHOCEL™

Applications : Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions

Pharmacopoeia Ref : Not Available

Technical Specs : Not Available

Grade : Not Available

arrow
blank

27

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

32

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : VCAPS® ENTERIC

Applications : It offers an enteric-release profile to the upper gastro-intestinal tract that meets the disintegration requirements for delayed-release capsules for the European, US and Japanese Phamacopoeia.

Pharmacopoeia Ref : Complies with relevant European, Japanese and US Pharmacopeia monographs

Technical Specs : Water content – less than 6%; Size #0

Grade : Oral

arrow
blank

35

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : CARBOPOL 971P NF

Applications : Carbopol® 971P NF polymer is used in oral & mucosal contact applications such as extended/controlled release tablets, oral liquids, suspension & bioadhesive formulations. The residual solvent of Carbopol 971P NF is Ethyl acetate.

Pharmacopoeia Ref : United States Pharmacopeia/National Formulary (USP/NF) monograph for Carbomer Homopolymer Type A, European Pharmacopeia (Ph. Eur.), India Pharmacopeia (IP), China Pharmacopeia (ChP) monographs for Carbomers.

Technical Specs : Viscosity, cP (0.5 wt% at pH 7.5)- 4,000 - 11,000

Grade : Oral & Topical

arrow
blank

37

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : CARBOPOL 974P NF

Applications : Carbopol® 974P NF polymer is used in oral and mucosal contact applications such as oral liquids, bioadhesive formulations, & extended release tablets. Additionally, it can be used to formulate viscous gels, emulsions & suspensions.

Pharmacopoeia Ref : United States Pharmacopeia/National Formulary (USP/NF) monograph for Carbomer Homopolymer Type B, European Pharmacopeia (Ph. Eur.), India Pharmacopeia (IP), China Pharmacopeia (ChP) mongographs for Carbomers.

Technical Specs : Viscosity, cP (0.5 wt% at pH 7.5)- 29,400 - 39,400

Grade : Oral & Topical

arrow
blank

43

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : ACRYPOL 971

Applications : It is widely used in oral solid, liquid dosage forms & topical formulations. It acts as excellent gel matrix former for controlling drug release in solid dosage forms.

Pharmacopoeia Ref : USP/NF : Carbomer Homopolymer Type A, EP : Carbomers

Technical Specs : Not Available

Grade : Oral and Topical

arrow
blank

44

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : ACRYPOL 971G

Applications : It is widely used in oral solid, liquid dosage forms & topical formulations. It acts as excellent gel matrix former for controlling drug release in solid dosage forms.

Pharmacopoeia Ref : USP/NF: Carbomer Homopolymer Type A, EP : Carbomers

Technical Specs : Not Available

Grade : Oral and Topical

arrow
blank

45

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : ACRYPOL 971P

Applications : It is widely used in oral solid, liquid dosage forms & topical formulations. It acts as excellent gel matrix former for controlling drug release in solid dosage forms.

Pharmacopoeia Ref : USP/NF : Carbomer Homopolymer Type A, EP : Carbomers

Technical Specs : Not Available

Grade : Oral and Topical

arrow
blank

46

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : KOLLICOAT SR 30 D

Applications : pH-independent sustained release coating for small particles, pellets, granules and tablets. Sprayable polymeric film former. Flexible. Wash resistant.

Pharmacopoeia Ref : Ph. Eur.: Poly(vinyl acetate) dispersion 30 per cent; USP: Polyvinyl Acetate Dispersion

Technical Specs : Not Available

Grade : Not Available

arrow
blank

47

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : ACRYPOL 941

Applications : It is widely used in oral solid, liquid dosage forms & topical formulations. It acts as excellent gel matrix former for controlling drug release in solid dosage forms.

Pharmacopoeia Ref : USP/NF : Carbomer 941

Technical Specs : Not Available

Grade : Oral and Topical

arrow
blank

48

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : ACRYFLOW S

Applications : Lipophilic lubricant, Acryflow is used as an emulsifier for oil-in-water emulsions and as a pH independent sustained release agent. It acts as a plasticizer in solid dispersions.

Pharmacopoeia Ref : USP/NF: Hydrogenated Castor Oil EP: Castor Oil, Hydrogenated

Technical Specs : Not Available

Grade : Oral and Topical

arrow
blank

49

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand Name : Soluplus

Excipient Details : Solubility and bioavailability enhancement, ideal for hot melt extrusion (HME)

Pharmacopoeia Ref : Polyvinyl caprolactam – poly...

Technical Specs :

Grade :

arrow

Brand : SOLUPLUS

Applications : Solubility and bioavailability enhancement, ideal for hot melt extrusion (HME)

Pharmacopoeia Ref : Polyvinyl caprolactam – polyvinyl acetate – polyethylene glycol graft copolymer

Technical Specs : Not Available

Grade : Not Available

arrow
blank